Maximize Your Impact at AI in Drug Discovery 2026
AI in Drug Discovery 2026, taking place on September 3, brings together global leaders in pharmaceutical R&D, AI-driven biotechnology, and computational biology at Hilton London Kensington in London, England. As artificial intelligence continues to influence how therapies are discovered, optimized, and commercialized, this event is strategically positioned at the intersection of healthcare innovation and emerging technologies.
The conference attracts senior-level decision-makers from pharmaceutical companies, biotech firms, research institutions, and AI technology providers. These attendees are actively evaluating investments, forming research partnerships, and selecting platforms that will shape their discovery pipelines for years to come. Early outreach is key, as many participants come with mandates to explore new AI tools, allocate budget toward next-gen R&D platforms, and identify collaboration opportunities. With access to Vendelux’s enriched attendee list, your team can understand each executive’s area of focus, company priorities, and current technology landscape to initiate meaningful conversations ahead of the event.
How Sales, Marketing and Revops Teams Can Use This Attendee List
AI in Drug Discovery 2026 offers strong engagement potential for sales, marketing, and revenue operations teams targeting biopharma, life sciences, and AI software sectors. The enriched conference attendee list allows you to segment contacts based on R&D focus, funding stage, or commercial readiness.
Sales teams can prioritize C-level executives and scientific leaders who directly influence AI adoption, research funding, or platform integration. Marketers can craft content that aligns with specific discovery approaches, such as generative chemistry models or clinical trial optimization tools. RevOps teams can map key accounts and assign outreach efforts based on therapeutic area or enterprise size.
This list also supports early meeting scheduling with budget owners evaluating tools for hit-to-lead screening, molecule design, or translational science. Engage these executives before the show to set context, align on shared goals, and turn booth visits into future collaborations. Post-event, use attendee data to personalize follow-ups with actionable touchpoints, such as research insights, ROI case studies, or joint development proposals. Knowing how to get more meetings means speaking directly to what these decision-makers care about—and doing it long before they walk the exhibit floor.
Timing Is Everything
AI in Drug Discovery 2026 will be held on September 3, 2026. With just a single-day program, each minute counts, and scheduling meetings in advance is a priority. Engage with conference attendees early to secure time with directors of research, innovation officers, and AI partners before their calendars close.
By using Vendelux to access and analyze the enriched attendee list, you can identify high-priority contacts early and plan targeted outreach that encourages scheduled conversations at the event. Aligning your touchpoints to key bioscience trends or AI strategies well before the fall puts your team in a strong position to build real momentum at the event.
What’s Included in the AI in Drug Discovery 2026 Attendee List?
Vendelux provides visibility into executives expected to attend AI in Drug Discovery 2026 by combining organizer data with predictive insights. Clients can upload their list of high-value accounts and see where their contacts appear within the attendee database.
The enriched attendee list includes first and last names, job titles, company name, company website, physical location (city, state, and country), LinkedIn profiles, verified email addresses, and, when available, phone numbers.
Where Is AI in Drug Discovery 2026?
The event will take place at Hilton London Kensington in London, England, United Kingdom.
When Is AI in Drug Discovery 2026?
AI in Drug Discovery 2026 is scheduled for September 3, 2026.
What Type of Event Is AI in Drug Discovery 2026?
AI in Drug Discovery 2026 is a one-day, industry-focused conference that brings together researchers, executives, and innovators from life sciences and technology. The event features keynote presentations, technical panels, case studies, and networking sessions that explore how artificial intelligence is advancing drug discovery and development processes.
How Many People Attend AI in Drug Discovery 2026?
AI in Drug Discovery 2026 is expected to attract more than 300 attendees from across the United Kingdom, Europe, North America, and Asia. The audience includes VP-level and C-suite leaders in drug discovery, data science, translational research, and AI strategy.
